GSK: The Rebirth of a Century-Old Pharma Diagram

失败与踩坑

• The 2020 COVID-19 vaccine collaboration …
• Selling the oncology pipeline in 2014 le…
• The 2026 closure of the century-old Dres…
• Stock performance underperformed peers d…

关键成功要素

• Streamlining the financial structure via…
• Betting on high-value vaccine products w…
• Building a comprehensive HIV portfolio a…
• Acknowledging the lag in mRNA platforms …
• Using the number of Phase III pipeline a…

经验教训

• The cost of strategic vacillation in lar…
• Spinning off low-growth businesses is no…
• Super-windows like a pandemic cannot be …
• There is no room for complacency before …
• The painful decision to close a century-…